share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

诺瓦瓦克斯医药 | 4:持股变动声明-董事 YOUNG JAMES F
美股SEC公告 ·  01/03 05:46

Moomoo AI 已提取核心信息

James F. Young, an insider at Novavax, has planned to sell a total of 10,000 shares of common stock in two transactions. The first sale of 4,600 shares is scheduled for 12/24/2024 at $8.48 per share, followed by a second sale of 5,400 shares on 12/31/2024 at $8.00 per share.The total market value of the disposed shares amounts to $82,208. After these transactions, Young's remaining direct ownership in Novavax will be 51,760 shares. Both sales are classified as open market or private sales.These planned transactions indicate a reduction in Young's stake in Novavax, with the sales occurring at slightly different price points over a week-long period. The company has not provided any additional context for these insider sales.
James F. Young, an insider at Novavax, has planned to sell a total of 10,000 shares of common stock in two transactions. The first sale of 4,600 shares is scheduled for 12/24/2024 at $8.48 per share, followed by a second sale of 5,400 shares on 12/31/2024 at $8.00 per share.The total market value of the disposed shares amounts to $82,208. After these transactions, Young's remaining direct ownership in Novavax will be 51,760 shares. Both sales are classified as open market or private sales.These planned transactions indicate a reduction in Young's stake in Novavax, with the sales occurring at slightly different price points over a week-long period. The company has not provided any additional context for these insider sales.
诺瓦瓦克斯医药的内部人士詹姆斯·F·杨计划通过两笔交易总共出售10,000股普通股。第一次出售4,600股定于2024年12月24日,价格为每股8.48美元,随后在2024年12月31日进行第二次出售5,400股,价格为每股8.00美元。出售的股票总市值达到82,208美元。在这两笔交易后,杨在诺瓦瓦克斯医药的直接持股量将剩余51,760股。这两笔交易均被归类为公开市场交易或私人交易。这些计划中的交易表明杨在诺瓦瓦克斯医药的股份减少,这些销售在一周的时间内发生,价格略有不同。该公司没有为这些内部销售提供任何额外的背景信息。
诺瓦瓦克斯医药的内部人士詹姆斯·F·杨计划通过两笔交易总共出售10,000股普通股。第一次出售4,600股定于2024年12月24日,价格为每股8.48美元,随后在2024年12月31日进行第二次出售5,400股,价格为每股8.00美元。出售的股票总市值达到82,208美元。在这两笔交易后,杨在诺瓦瓦克斯医药的直接持股量将剩余51,760股。这两笔交易均被归类为公开市场交易或私人交易。这些计划中的交易表明杨在诺瓦瓦克斯医药的股份减少,这些销售在一周的时间内发生,价格略有不同。该公司没有为这些内部销售提供任何额外的背景信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息